[1]Kurra S,Siris E.Diabetes and bone health:the relationship between diabetes and osteoporosisassociated fractures[J].Diabetes Metab Res Rev,2011,27(5):430-435.
[2]Mobasheri A,Vannucci SJ,Bondy CA,et al.Glucose transport and metabolism in chondrocytes:A key to understanding chondrogenesis,skeletal development and cartilage degradation in osteoarthritis[J].Histol Histopathol,2002,17(4):1239-1267.
[3]Mieczkowska A,Irwin N,Flatt PR,et al.Glucose-dependent insulinotropic polypeptide (GIP)receptor deletion leads to reduced bone strength and quality[J].Bone,2013,56(2):337-42.
[4]Xie D,Zhong Q,Ding KH,et al.Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass[J].Bone,2007,40(5):1352-1360.
[5]Xie D,Cheng H,Hamrick M,et al.Glucose-dependent insulinotropic polypeptide receptor knockout mice havealtered bone turnover[J].Bone,2005,37(6):759-769.
[6]莫其斌.浅析骨性关节炎治疗的药物选择[J].中国民族民间医药,2011,20(19):43-45.
[7]Wolffbrandt KH,Damm Jorgensen K,Moody AJ,et al.The effects of porcine GIP on insulin secretion and glucose clearance in the pig[J].Horm Metab Res,1986,18(3):159-162.
[8]Kieffer TJ.Gastro-intestinal hormones GIP and GLP-1[J].Ann Endocrinol,2004,65(1):13-21.
[9]Ugleholdt R.Glucose-dependent insulinotropic polypeptide (GIP):from prohormone to actions in endocrine pancreas and adipose tissue[J].Dan Med Bull,2011,58(12):4368-4369.
[10]Bollag RJ,Zhong Q,Phillips P,et al.Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors[J].Endocrinology,2000,141(3):1228-1235.
[11]Usdin TB,Mezey E,Button DC,et al.Gastric inhibitory polypeptide receptor,a member of the secretin-vasoactive intestinal peptide receptor family,is widely distributed in peripheral organs and the brain[J].Endocrinology,1993,133(6):2861-2870.
[12]Ehses JA,Pelech SL,Pederson RA,et al.Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway[J].J Biol Chem,2002,277(40):37088-37097.
[13]Ramsey W,Isales CM.Intestinal incretins and the egulation of 不one hysiology[J].Adv Exp Med Biol,2017,1033(2):13-33.
[14]Rosa SC,Goncalves J,Judas F,et al.Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage[J].Arthritis Res Ther,2009,11(3):80-104.
[15]Napoli N,Strollo R,Paladini A,et al.The Alliance of mesenchymal stem cells,bone,and diabetes[J].Int J Endocrinol,2014,2014(2014):690783-690809.
[16]Velasquez MT1,Katz JD.Osteoarthritis:Another component of metabolic syndrome?[J].Metab Syndr Relat Disord,2010,8(4):295-305.
[17]吴松,石俊俊,卫定禄,等.DAla2GIP对淀粉样前体蛋白/早老素1转基因小鼠膝关节软骨损伤保护效应的研究[J].中华实验外科杂志,2017,34(11):1861-1864.
[18]Mieczkowska A,Bouvard B,Chappard D,et al.Glucose dependent insulinotropic polypeptide (GIP)directly affects collagen fibril diameter and collagen cross-linking in osteoblastcultures[J].Bone,2015,74(1):29-36.
[19]Nissen A,Christensen M,Knop FK,et al.Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans[J].J Clin Endocrinol Metab,2014,99(11):E2325-2329.
[20]Tsukiyama K,Yamada Y,Yamada C,et al.Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion[J].Mol Endocrinol,2006,20(7):1644-1651.
[21]Mieczkowska A,Irwin N,Flatt PR,et al.Glucose-dependent insulinotropic polypeptide (GIP)receptor deletion leads to reduced bone strength and quality[J].Bone,2013,56(2):337-342.